256
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients

, , , , &
Pages 1457-1467 | Published online: 30 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Qin Lang, Lijuan Li, Yue Zhang, Xing He, Yafeng Liu, Zhen Liu & Haiying Yan. (2023) Development and Validation of a Diagnostic Nomogram for Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Pneumonia Patients Undergoing Oral Glucocorticoid Treatment. Infection and Drug Resistance 16, pages 755-767.
Read now
R. Benson Weyant, Dima Kabbani, Karen Doucette, Cecilia Lau & Carlos Cervera. (2021) Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opinion on Pharmacotherapy 22:12, pages 1579-1592.
Read now
Catia Cillóniz, Cristina Dominedò, Míriam J Álvarez-Martínez, Asunción Moreno, Felipe García, Antoni Torres & José M Miro. (2019) Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients. Expert Review of Anti-infective Therapy 17:10, pages 787-801.
Read now

Articles from other publishers (25)

Jiechao Niu, Jiandong Wang, Peisheng Jia, Mengjiao Zhang & Erhu Wei. (2023) Clinical features and diagnostic value of metagenomic next -generation sequencing in five cases of non-HIV related Pneumocystis jirovecii pneumonia in children. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Erica Franceschini, Giovanni Dolci, Antonella Santoro, Marianna Meschiari, Alice Riccò, Marianna Menozzi, Giulia Jole Burastero, Biagio Cuffari, Nicola De Maria, Lucia Serio, Emanuela Biagioni, Barbara Catellani, Stefano Di Sandro, Antonio Colecchia, Massimo Girardis, Fabrizio Di Benedetto & Cristina Mussini. (2023) Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series. International Journal of Infectious Diseases 128, pages 254-256.
Crossref
Zhaolun Li & David W. Denning. (2023) The Impact of Corticosteroids on the Outcome of Fungal Disease: a Systematic Review and Meta-analysis. Current Fungal Infection Reports 17:1, pages 54-70.
Crossref
Xiao-Yu Cai, Yi-Chun Cheng, Shu-Wang Ge & Gang Xu. (2023) Clinical characteristics and risk factor analysis of Pneumocystis jirovecii pneumonia in patients with CKD: a machine learning–based approach. European Journal of Clinical Microbiology & Infectious Diseases 42:3, pages 323-338.
Crossref
Chiwook Chung, Chae Man Lim, Yeon-Mok Oh, Sang Bum Hong, Chang-Min Choi, Jin Won Huh, Sei Won Lee, Jae Seung Lee, Kyung-Wook Jo, Wonjun Ji, Chan-Jeoung Park, Mina Kim, Heungsup Sung, Young-Uk Cho, Hyo Sin Cho & Ho Cheol Kim. (2022) Prognostic implication of bronchoalveolar lavage fluid analysis in patients with Pneumocystis jirovecii pneumonia without human immunodeficiency virus infection. BMC Pulmonary Medicine 22:1.
Crossref
Yi-Min Huang, Cheng-Hsun Lu, Chiao-Feng Cheng, Chieh-Yu Shen, Song-Chou Hsieh, Ko-Jen Li, Jung-Yien Chien & Po-Ren Hsueh. (2022) Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia. International Journal of Infectious Diseases 122, pages 1018-1025.
Crossref
Zichu Zhao, Yanli Huang, Bingxia Ming, Jixin Zhong & Lingli Dong. (2022) Characterization and associated risk factors of Pneumocystis jirovecii pneumonia in patients with AIRD: a retrospective study . Rheumatology 61:9, pages 3766-3776.
Crossref
Mohamed Nasr, Amad Mohammad, Mosab Hor, Ahmed M Baradeiya & Hodan Qasim. (2022) Exploring the Differences in Pneumocystis Pneumonia Infection Between HIV and Non-HIV Patients. Cureus.
Crossref
Giorgio Bozzi, Paola Saltini, Malvina Matera, Valentina Morena, Valeria Castelli, Anna Maria Peri, Lucia Taramasso, Riccardo Ungaro, Andrea Lombardi, Antonio Muscatello, Patrizia Bono, Anna Grancini, Anna Maraschini, Caterina Matinato, Andrea Gori & Alessandra Bandera. (2022) Pneumocystis jirovecii pneumonia in HIV-negative patients, a frequently overlooked problem. A case series from a large Italian center. International Journal of Infectious Diseases 121, pages 172-176.
Crossref
Marwan M Azar, Elizabeth Cohen, Liang Ma, Ousmane H Cissé, Geliang Gan, Yanhong Deng, Kristen Belfield, William Asch, Matthew Grant, Shana Gleeson, Alan Koff, David C Gaston, Jeffrey Topal, Shelly Curran, Sanjay Kulkarni, Joseph A Kovacs & Maricar Malinis. (2022) Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States . Clinical Infectious Diseases 74:4, pages 639-647.
Crossref
Yuqiong Wang, Xu Huang, Ting Sun, Guohui Fan, Qingyuan Zhan & Li Weng. (2022) Non‐HIV‐infected patients with Pneumocystis pneumonia in the intensive care unit: A bicentric, retrospective study focused on predictive factors of in‐hospital mortality . The Clinical Respiratory Journal 16:2, pages 152-161.
Crossref
Adélaïde Chesnay, Christophe Paget, Nathalie Heuzé-Vourc’h, Thomas Baranek & Guillaume Desoubeaux. (2022) Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model. Journal of Fungi 8:2, pages 129.
Crossref
Julien Senécal, Elizabeth Smyth, Olivier Del Corpo, Jimmy M. Hsu, Alexandre Amar-Zifkin, Amy Bergeron, Matthew P. Cheng, Guillaume Butler-Laporte, Emily G. McDonald & Todd C. Lee. (2022) Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. Clinical Microbiology and Infection 28:1, pages 23-30.
Crossref
Li Liu, Mingjuan Yuan, Yi Shi & Xin Su. (2021) Clinical Performance of BAL Metagenomic Next-Generation Sequence and Serum (1,3)-β-D-Glucan for Differential Diagnosis of Pneumocystis jirovecii Pneumonia and Pneumocystis jirovecii Colonisation. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Jumpei Taniguchi, Kei Nakashima, Hiroki Matsui, Tomohisa Watari, Ayumu Otsuki, Hiroyuki Ito & Yoshihito Otsuka. (2021) Low cut-off value of serum (1,3)-beta-d-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study. BMC Infectious Diseases 21:1.
Crossref
Stine Grønseth, Tormod Rogne, Raisa Hannula, Bjørn Olav Åsvold, Jan Egil Afset & Jan Kristian Damås. (2021) Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway. BMC Infectious Diseases 21:1.
Crossref
Fan Jin, Jing Xie & Huan-ling Wang. (2021) Lymphocyte subset analysis to evaluate the prognosis of HIV-negative patients with pneumocystis pneumonia. BMC Infectious Diseases 21:1.
Crossref
Anupop Jitmuang, Anapat Nititammaluk, Thitaya Boonsong, Patsharaporn Techasintana Sarasombath, Suree Sompradeekul & Methee Chayakulkeeree. (2021) A novel droplet digital polymerase chain reaction for diagnosis of Pneumocystis pneumonia (PCP)-a clinical performance study and survey of sulfamethoxazole-trimethoprim resistant mutations. Journal of Infection 83:6, pages 701-708.
Crossref
Heval Can BİLEK, Aydın DEVECİ & Esra TANYEL. (2021) Pneumocystis Jirovecii Pneumonia In HIV-Infected Patients: A Single Center ExperienceHIV ile Enfekte Hastalarda Pneumocystis Jirovecii Pnömonisi: Tek Merkez Deneyimi. Mustafa Kemal Üniversitesi Tıp Dergisi 12:43, pages 131-135.
Crossref
Huan-Yi Wu, Kuan-Sheng Wu, Yi-Luan Huang, Shr-Hau Dai, Ding-Yu Chang, Shu-Hung Kuo, Shun-Yi Chen, Chih-Chen Chou, Ya-Wei Weng, Yu-Ting Tseng, Jui-Kuang Chen, Cheng-Len Sy, Hung-Chin Tsai, Susan Shin-Jung Lee & Yao-Shen Chen. (2021) Identifying predictors for bacterial and fungal coinfection on chest computed tomography in patients with Pneumocystis pneumonia. Journal of Microbiology, Immunology and Infection 54:4, pages 701-709.
Crossref
Guoxing Tang, Shutao Tong, Xu Yuan, Qun Lin, Ying Luo, Huijuan Song, Wei Liu, Shiji Wu, Liyan Mao, Weiyong Liu, Yaowu Zhu, Ziyong Sun & Feng Wang. (2021) Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis jiroveci Pneumonia in Immunocompromised Patients. Frontiers in Immunology 12.
Crossref
Lin Ding, Huixue Huang, Heyan Wang & Hangyong He. (2020) Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies. Annals of Intensive Care 10:1.
Crossref
José M. Porcel. (2020) Pleural diseases and COVID-19: ubi fumus, ibi ignis . European Respiratory Journal 56:5, pages 2003308.
Crossref
Lijuan Li, Steven H Hsu, Xiaoying Gu, Shan Jiang, Lianhan Shang, Guolei Sun, Lingxiao Sun, Li Zhang, Chuan Wang, Yali Ren, Jinxiang Wang, Jianliang Pan, Jiangbo Liu & Cao Bin. (2020) Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study. BMJ Open 10:10, pages e037419.
Crossref
Olivier Del Corpo, Guillaume Butler-Laporte, Donald C. Sheppard, Matthew P. Cheng, Emily G. McDonald & Todd C. Lee. (2020) Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. Clinical Microbiology and Infection 26:9, pages 1137-1143.
Crossref